When the inactive form of myostatin is blocked, it cannot become active, and muscle growth is not suppressed.
From The Ultimate Peptide Stack? Gain Muscle, Lose Fat! · videoSee the scientific wording
Inhibition of the precursor form of myostatin prevents its proteolytic activation and results in reduced suppression of skeletal muscle growth.
Very strong evidence
Mixed evidence6 high-quality studies support this claim.
What the research says
6 studies reviewedSupporting (6)
Randomized Controlled TrialHuman2026
This drug stops a protein called myostatin from slowing down muscle growth. People who got the drug kept more muscle while losing weight, compared to those who didn’t — proving it works as intended.
Cohort StudyHuman2026
People born with a broken myostatin gene have more muscle and less fat because myostatin normally stops muscles from growing—so if it's broken, muscles grow bigger.
Cohort StudyAnimal2025
The study used a special bacteria to trick the body into making antibodies that block myostatin, the muscle-growth stop signal. This helped mice move better and showed less muscle damage, meaning blocking myostatin worked — even if muscles didn’t get bigger because the disease was too advanced.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
A protein that stops muscles from growing is made in an inactive form first. A special molecule binds to this inactive form and blocks it from being cut into its active version. Without the active version, muscles do not receive the signal to stop growing, so they get bigger and stronger because they build more protein and break down less.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 6 supporting studies
Related videos
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
When the inactive form of myostatin is blocked, it cannot become active, and muscle growth is not suppressed.
Mechanism
6 studiesA protein that stops muscles from growing is made in an inactive form first. A molecule binds to this inactive form and blocks it from being cut into its active version. Without the active version, muscles do not receive the signal to stop growing, so they get bigger and stronger because they build more protein and break down less.
A protein that stops muscles from growing is made in an inactive form first. A special molecule binds to this inactive form and blocks it from being cut into its active version. Without the active version, muscles do not receive the signal to stop growing, so they get bigger and stronger because they build more protein and break down less.
Myostatin is synthesized as an inactive precursor protein that remains bound to its prodomain in a latent complex within the extracellular space of skeletal muscle.
A specific inhibitor binds to the latent myostatin precursor with high affinity, preventing proteolytic cleavage by tolloid-family proteases and proprotein convertases.
Blocking cleavage prevents the release of the mature myostatin growth factor from the latent complex.
The absence of mature myostatin prevents binding to ActRIIB receptors on skeletal muscle cells.
Inhibition of ActRIIB receptor activation reduces phosphorylation of SMAD2 and SMAD3 transcription factors.
Reduced SMAD2/3 signaling decreases expression of atrophy-related genes such as MuRF1 and Atrogin-1, and removes suppression of protein synthesis pathways.
The net effect is increased muscle protein content, satellite cell activation, and myofiber hypertrophy, resulting in greater skeletal muscle mass and strength.
Evidence from Studies
Last searched 2mo ago
Supporting (6)
Community contributions welcome
Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial
This drug stops a protein called myostatin from slowing down muscle growth. People who got the drug kept more muscle while losing weight, compared to those who didn’t — proving it works as intended.
People born with a broken myostatin gene have more muscle and less fat because myostatin normally stops muscles from growing—so if it's broken, muscles grow bigger.
The study used a special bacteria to trick the body into making antibodies that block myostatin, the muscle-growth stop signal. This helped mice move better and showed less muscle damage, meaning blocking myostatin worked — even if muscles didn’t get bigger because the disease was too advanced.
Blocking extracellular activation of myostatin as a strategy for treating muscle wasting
Scientists made a special antibody that stops a protein called myostatin from becoming active. When they gave it to mice, their muscles got bigger and stronger—proving that blocking this protein helps muscles grow.
Preclinical Safety Assessment and Toxicokinetics of Apitegromab, an Antibody Targeting Proforms of Myostatin for the Treatment of Muscle-Atrophying Disease
This study used a special antibody to block the inactive version of a muscle-limiting protein, and as a result, the rats grew bigger muscles without any side effects — proving that stopping the inactive form from turning active helps muscles grow.
When scientists blocked the signal that myostatin uses to stop muscles from growing, the mice kept their muscle mass even when given steroids that normally make muscles shrink. So blocking myostatin’s signal helps muscles stay strong.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Myostatin Precursor Inhibition on Muscle Mass in Animal and Human Studies
Systematic review and meta-analysis of all published controlled studies evaluating myostatin precursor inhibition, comparing muscle mass outcomes across intervention and control groups in human and animal models.
Double-Blind RCT of Myostatin Precursor Blocker vs Placebo on Skeletal Muscle Mass in Healthy Adults
Randomized, double-blind, placebo-controlled trial in healthy adult humans, administering a myostatin precursor blocker versus placebo for 12 weeks, measuring changes in lean muscle mass via DEXA.
Prospective Cohort Study of Natural Myostatin Precursor Variants and Muscle Mass in a Longitudinal Population
Prospective cohort study following a large population over 5 years, measuring genetic variants affecting myostatin precursor processing and tracking longitudinal changes in muscle mass.
In Vitro Analysis of Myostatin Precursor Inhibition on Myoblast Differentiation and Myotube Formation
In vitro experiment using human myoblast cell lines treated with a specific myostatin precursor inhibitor, measuring pro-myostatin cleavage via Western blot and myotube formation via immunofluorescence.
Mouse Model Study of Myostatin Precursor Knockdown on Skeletal Muscle Hypertrophy
Transgenic or pharmacologically treated mouse model with targeted inhibition of myostatin precursor cleavage, measuring muscle fiber size and total muscle mass over 8 weeks compared to wild-type controls.